Inovio Selected by CEPI to Develop Vaccine Against New Coronav...
PLYMOUTH MEETING, Pa., Jan. 24, 2020 /PRNewswire-AsiaNet/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV)...
Authors: LATEST ASIANET NEWS RELEASES